HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keitaro Kai Selected Research

PD 128042

6/2022Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keitaro Kai Research Topics

Disease

1Lymphoma (Lymphomas)
06/2022
1Neoplasms (Cancer)
06/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Aneurysm (Aneurysms)
12/2018

Drug/Important Bio-Agent (IBA)

1PD 128042IBA
06/2022
1CholesterolIBA
06/2022
1LipidsIBA
06/2022
1InterleukinsIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2022
1NF-kappa B (NF-kB)IBA
01/2022
1Polymethyl Methacrylate (Sol)IBA
12/2018

Therapy/Procedure

1Therapeutics
01/2022
1Craniotomy
12/2018